Interferon, alpha 13 (IFNA13) (C-Term) Peptide
IFNA13
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all IFNA13 products
- IFNA13 (Interferon, alpha 13 (IFNA13))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ILAVKKYFRR ITLYLTEKKY SPCAWEVVRA EIMRSLSLST NLQERLRRKE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-IFNA13 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IFNA13 (Interferon, alpha 13 (IFNA13))
- Synonyms
- interferon alpha-1/13 Peptide, interferon, alpha 13 Peptide, interferon alpha 13 Peptide, interferon alpha family, gene 13 Peptide, LOC473197 Peptide, IFNA13 Peptide, LOC742651 Peptide, Ifna13 Peptide
- Background
-
IFNA13 is produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.
Alias Symbols: IFNA1
Protein Size: 189 - Molecular Weight
- 21 kDa
- Gene ID
- 3447
- NCBI Accession
- NM_006900, NP_008831
- UniProt
- P01562
-
You are here:
